In case the authors read HN:

In the case of Achromatopsia, the low and high ends are ambiguous. Since the condition affects 1 in 30,000 individuals (or 0.00003%), Turbo should be usable by 99.997% of the population.

1 in 30,000 is 0.003%, not 0.00003%.